Bloxiverz
RxNorm concept 1429278, brand name (bn).
- RxCUI
- 1429278
- Term type
- Brand name (BN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1429278 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- neostigmine methylsulfate (PIN, has precise ingredient)
- neostigmine Injectable Solution [Bloxiverz] (SBDF, ingredient of)
- Bloxiverz Injectable Product (SBDG, ingredient of)
- neostigmine methylsulfate 0.5 MG/ML Injectable Solution [Bloxiverz] (SBD, ingredient of)
- neostigmine methylsulfate 1 MG/ML Injectable Solution [Bloxiverz] (SBD, ingredient of)
- neostigmine methylsulfate 0.5 MG/ML [Bloxiverz] (SBDC, ingredient of)
- neostigmine methylsulfate 1 MG/ML [Bloxiverz] (SBDC, ingredient of)
- neostigmine Prefilled Syringe [Bloxiverz] (SBDF, ingredient of)
- 5 ML neostigmine methylsulfate 1 MG/ML Prefilled Syringe [Bloxiverz] (SBD, ingredient of)
- neostigmine (IN, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1429278 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1429278 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1429278. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.